Antithymocyte immunoglobulin (rabbit)
- Generic Name
- Antithymocyte immunoglobulin (rabbit)
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 308067-60-9
- Unique Ingredient Identifier
- D7RD81HE4W
- Background
Rabbit anti-thymocyte globulin. Thymoglobulin is a polyclonal antibody that suppresses certain types of immune cells responsible for acute organ rejection in transplant patients. Thymoglobulin is a mixture of antibodies intended to bind to various cell surface antigens. The most common mode of action of Thymoglobulin is via selective depletion of T-cells.
- Indication
For prevention of renal transplant rejection
- Associated Conditions
- Rejection Acute Renal
- Associated Therapies
- -
Randomized Trial of Induction Therapies in High Immunological Risk Kidney Transplant Recipients
- Conditions
- Interventions
- First Posted Date
- 2008-10-31
- Last Posted Date
- 2016-01-20
- Lead Sponsor
- University of Cincinnati
- Target Recruit Count
- 40
- Registration Number
- NCT00782821
- Locations
- 🇺🇸
The Christ Hospital, Cincinnati, Ohio, United States
🇺🇸The University Hospital, Cincinnati, Ohio, United States
Prospective Pilot Study of Pre-Transplant Thymoglobulin Administration in Living Donor Renal Transplant Recipients
- Conditions
- Interventions
- First Posted Date
- 2008-10-13
- Last Posted Date
- 2016-01-18
- Lead Sponsor
- University of Cincinnati
- Target Recruit Count
- 11
- Registration Number
- NCT00771745
- Locations
- 🇺🇸
The Christ Hospital, Cincinnati, Ohio, United States
Thymoglobulin in Calcineurin Inhibitor and Steroid Minimization Protocol
- First Posted Date
- 2008-06-27
- Last Posted Date
- 2008-06-27
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 30
- Registration Number
- NCT00706680
- Locations
- 🇨🇦
University health Network, Toronto, Ontario, Canada
🇨🇦St Michael's Hospital, Toronto, Ontario, Canada
🇨🇦St Paul's Hospital, Vancouver, British Columbia, Canada
Autologous Stem Cell Transplantation for Crohn's Disease
- First Posted Date
- 2008-06-06
- Last Posted Date
- 2024-02-14
- Lead Sponsor
- Paul Szabolcs
- Target Recruit Count
- 20
- Registration Number
- NCT00692939
- Locations
- 🇺🇸
UPMC Prebyterian- Adult Gastroenterology, Pittsburgh, Pennsylvania, United States
🇺🇸Children's Hospital of Pittsburgh of UPMC-Bone Marrow Team, Pittsburgh, Pennsylvania, United States
Thymoglobulin Versus Campath-1H Versus Daclizumab in Adult, Primary Deceased Donor Renal Transplantation
- Conditions
- Interventions
- First Posted Date
- 2008-05-28
- Last Posted Date
- 2023-10-18
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 90
- Registration Number
- NCT00685061
- Locations
- 🇺🇸
University of Miami Division of Transplantation, Miami, Florida, United States
Thymoglobulin Versus Campath-1H Versus Daclizumab in Adult, Primary Living Donor Renal Transplantation
- Conditions
- Interventions
- First Posted Date
- 2008-05-21
- Last Posted Date
- 2023-09-14
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 38
- Registration Number
- NCT00681343
- Locations
- 🇺🇸
University of Miami Division of Transplantation, Miami, Florida, United States
Allogeneic Transplantation for Pediatric Leukemias With Unrelated Donors
- Conditions
- Interventions
- First Posted Date
- 2008-05-19
- Last Posted Date
- 2014-01-23
- Target Recruit Count
- 30
- Registration Number
- NCT00679536
- Locations
- 🇺🇸
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
Allogenic Stem Cell Transplantation in Patients With High Risk CD33+ AML/MDS/JMML
- First Posted Date
- 2008-05-01
- Last Posted Date
- 2015-04-22
- Lead Sponsor
- New York Medical College
- Target Recruit Count
- 12
- Registration Number
- NCT00669890
- Locations
- 🇺🇸
Morgan Stanley Children's Hospital of NYP, New York City, New York, United States
Autologous Transplant Followed by Allogeneic Transplant for High Risk Neuroblastoma
- Conditions
- Interventions
- First Posted Date
- 2008-05-01
- Last Posted Date
- 2016-06-24
- Lead Sponsor
- Columbia University
- Target Recruit Count
- 15
- Registration Number
- NCT00670410
- Locations
- 🇺🇸
Columbia Presbyterian Medical Center, Morgan Stanley Children's Hospital New York Presbyterian, New York, New York, United States
Prednisone Withdrawal Versus Prednisone Maintenance After Kidney Transplant
- Conditions
- Interventions
- First Posted Date
- 2008-01-17
- Last Posted Date
- 2017-05-15
- Lead Sponsor
- University of Pennsylvania
- Target Recruit Count
- 18
- Registration Number
- NCT00596947
- Locations
- 🇺🇸
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.